Cite

Copy

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Install/Install App' to create a shortcut app

Adjuvant Therapies for Chemotherapy for Medulloblastomas in Children

This page was last updated on January 25th, 2023

Radiation

  • Standard risk: Radiation treatment for standard-risk disease in children consists of craniospinal radiation of 2340 cGy plus a boost of 5400 cGy to the primary site of the tumor. Initially this boost was to the whole posterior fossa, but, more recently, conformal fields around the primary site of the tumor at diagnosis with a margin have been recommended.
  • High risk: Radiation treatment of high-risk medulloblastoma in children consists of craniospinal radiation of 3600 cGy plus a conformal boost to the posterior fossa of 5580 cGy and boosts to any metastases.
  • Vincristine during radiation: Weekly vincristine, 1.5 mg/m2 (maximum, 2 g) IV, has generally been used during radiation, but there is some controversy about the need for it.

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.